Details of the Drug
General Information of Drug (ID: DMGXVBA)
Drug Name |
2,3-DIMETHYL-1,4-NAPHTHOQUINONE
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
2,3-Dimethyl-1,4-naphthoquinone; 2,3-Dimethylnaphthoquinone; USAF SN-29; 2197-57-1; 1,4-Naphthalenedione, 2,3-dimethyl-; 2,3-dimethylnaphthalene-1,4-dione; UNII-SY9IO0B44O; SY9IO0B44O; 1,4-NAPHTHOQUINONE, 2,3-DIMETHYL-; NSC 36460; BRN 2044697; AI3-16112; 2,3-dimethyl-1,4-dihydronaphthalene-1,4-dione; AC1L28BU; AC1Q2DM1; SCHEMBL571026; CHEMBL354201; CTK4E8092; DTXSID50176380; MolPort-001-817-681; LGFDNUSAWCHVJN-UHFFFAOYSA-N; HMS1666O12; NSC36460; ZINC3063275; WLN: L66 BV EVJ C1 D1; 2,3-Dimethyl-[1,4]naphthoquinone; NSC-36460
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 186.21 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 1.7 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 0 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||